| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Taiwan | 4 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | Malaysia | 2 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | Hong Kong | 1 | |
| #7 | Japan | 1 | |
| #8 | United States | 1 | |
| #9 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chang Ming-Shi | 4 |
| #2 | Wu Hung-Ming | 3 |
| #3 | Chen Chia-Hui | 1 |
| #4 | Kung Liang-Rern | 1 |
| #5 | Cheng Ming-Ching | 1 |
| #6 | Chen Bin Ken | 1 |
| #7 | Chen Shan Chiung | 1 |
| #8 | Jang Shin-Hong | 1 |
| #9 | Pan Shiow Lin | 1 |
| #10 | Wu Hung Ming | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2016289313A1 | Antibodies which specifically bind to canine vascular endothelial growth factor and uses thereof | |
| TW200918094A | Pharmaceutical acceptable composition containing non-steroidal anti-inflammatory drug and local anesthetics | |
| TW200612954A | A pharmaceutical composition for inhibiting cell migration induced by an angiogenic factor | |
| MY130520A | Novel chinese herbal composition for improving blood circulation and the method of preparing the same |